Pradžia › Geltonosios dėmės degeneracija › Ohio
Geltonosios dėmės degeneracija klinikiniai tyrimai Ohio
11 tyrimai dėl Geltonosios dėmės degeneracija ieško dalyvių vietose Ohio.
Miestai Ohio
Oficialus tyrimo tekstas (anglų kalba)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Cincinnati Eye Institute (Site 133), Cincinnati
Renkami dalyviai2/3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Cincinnati Eye Institute, Cincinnati
- Cleveland Clinic Main Campus, Cleveland
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Associates of Cleveland - Beachwood, Beachwood
- Retina Associates of Cleveland, Cleveland
- Retina Associates of Cleveland - Middleburg Heights, Middleburg Heights
Renkami dalyviai1/2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Cincinnati Eye Institute, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Ohio State University, Columbus
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
- Cincinnati Eye Institute, Cincinnati
Renkami dalyviai1 fazė
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07734064Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
- Cleveland Clinic, Cleveland
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 50 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07798323Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Associates of Cleveland, Beachwood
Renkami dalyviai
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Cincinnati Eye Institute, Cincinnati
Renkami dalyviaiStebimasis tyrimas
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07425574Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Cincinnati Eye Institute, Cincinnati
Renkami dalyviai3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Cleveland Clinic | Cole Eye Institute, Cleveland
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2024-12-03 · NCT05438732Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.